SciBase Holding AB (FRA:5J3)
€ 0.019 0 (0%) Market Cap: 7.93 Mil Enterprise Value: 5.56 Mil PE Ratio: 0 PB Ratio: 2.40 GF Score: 31/100

SciBase Holding AB (publ) Collaboration with Johnson & Johnson Consumer Health Corporate Call Transcript

Nov 08, 2022 / NTS GMT
Release Date Price: €0.4205 (+11.84%)
Simon Grant;publ;CEO
SciBase Holding AB

()-

My name is Simon Grant and I'm the CEO of SciBase based here in Stockholm. We are traded on the Nasdaq Personals. I'm really happy today to be able to update you on the company progress and especially to discuss our announcement we made earlier today regarding our collaboration with Johnson & Johnson Consumer.

Today, I'm going to focus on three areas. The first area is the area of skin barrier, what it is, why it's important for diseases such as eczema or atopic dermatitis. The second thing I'm going to discuss is our collaboration with Johnson & Johnson, what it is, and what our goals are with that collaboration. And the third thing I'm going to talk about is skin barrier in general, what we see as the potential within this space, and why we're so excited about it.

For those of you that don't know SciBase, a quick introduction. We're a company working with skin disorders. And specifically, we work with unmet needs for dermatologists and allergists. We have developed a unique combination of two technologies:

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot